BioPlx Says It Can Stop Recurrent MRSA Cycles In Hospitals

Would Use Strain Substitution To Prevent Superbugs

 
• By Sten Stovall
  
Emerging Company Profile: BioPlx
Its non-antibiotic platform aims to control multiple-drug resistant infections • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip